CIK: 0001542339
Total reported value
$250.5M
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | ABMDEUR | Abiomed INC | Stock-Other | 28.32% | — | -34.70% | |
| 2 | RVNCEUR | Revance Therapeutics INC | Stock-Other | 22.44% | — | — | |
| 3 | ✓ | Corium Intl INC | Stock-Other | 18.39% | — | — | |
| 4 | AXGN | Axogen INC | Stock-Other | 16.69% | — | — | |
| 5 | ✓ | Entellus Medical INC | Stock-Other | 10.58% | — | — | |
| 6 | ✓ | Endologix INC | Stock-Other | 2.03% | — | — | |
| 7 | MNOV | Medicinova INC | Stock-Other | 1.32% | +0.14% | — | |
| 8 | ACUR | Acura Pharmaceuticals INC | Stock-Other | 0.16% | — | — | |
| 9 | ✓ | Catalyst Biosciences INC | Stock-Other | 0.07% | — | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | ✓ | Corium Intl INC | +5.8% | — | Unchanged |
| 2 | AXGN | Axogen INC | +2% | — | Unchanged |
| 3 | ✓ | Entellus Medical INC | +0.9% | — | Unchanged |
| 4 | RVNCEUR | Revance Therapeutics INC | +0.5% | — | Unchanged |
| 5 | MNOV | Medicinova INC | +0.2% | — | Unchanged |
| 6 | ✓ | Catalyst Biosciences INC | — | — | Unchanged |
| 7 | ACUR | Acura Pharmaceuticals INC | 0% | — | Unchanged |
| 8 | ✓ | Endologix INC | -0.1% | — | Unchanged |
| 9 | ABMDEUR | Abiomed INC | -9.3% | -34.70% | Trim |